Cervical Cancer section

Cervical Cancer News & Features

FDA panel unanimous on HPV test as Pap replacement

Experts voted 13-0 that a HPV test was safe and effective as first step in cervical cancer screening.

Targeted drug may prolong survival for patients with cervical cancer

A new clinical study has found that erlotinib has promising potential to improve treatment for cervical cancer.

Bevacizumab promising for advanced cervical cancer

Research has revealed that women with advanced cervical cancer live about 4 months longer with the combined use of bevacizumab and chemotherapy compared with chemotherapy alone.

FDA experts debate Pap test timing

Panel could recommend HPV test as a woman's new first option for cervical cancer screening.

Erlotinib plus cisplatin-based chemoradiation promising for cervical cancer

Treatment with epidermal growth factor receptor inhibitor erlotinib combined with cisplatin-based chemoradiation seems safe and effective for locally advanced cervical cancer, according to a study.

Cervical Cancer Videos

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs